Effets vasculaires et rénaux des médicaments anti-angiogéniques : recommandations françaises pour la pratique (SN, SFHTA, APNET, FFCD)-Reference-Cited by-同舟云学术

Effets vasculaires et rénaux des médicaments anti-angiogéniques : recommandations françaises pour la pratique (SN, SFHTA, APNET, FFCD)

Published:2008-12 Issue:7 Volume:4 Page:602-615
ISSN:1769-7255
Container-title:Néphrologie & Thérapeutique
language:fr
Short-container-title:Néphrologie & Thérapeutique

Author:

Halimi Jean-Michel,Azizi Michel,Bobrie Guillaume,Bouché Olivier,Deray Gilbert,des Guetz Gaetan,Lecomte Thierry,Levy Bernard,Mourad Jean-Jacques,Nochy Dominique,Oudard Stéphane,Rieu Philippe,Sahali Dil

Publisher

Elsevier BV

Subject

Nephrology

Reference61 articles.

1. Management of toxicity in patients receiving therapy with bevacizumab;Miles;Eur J Cancer,2008

2. Mechanisms of angiogenesis;Risau;Nature,1997

3. Vascular endothelial growth factor: basic science and clinical progress;Ferrara;Endocrine Rev,2004

4. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004

5. Sunitinib versus interferon alpha in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arterial Stiffness Changes in Adult Cancer Patients Receiving Anticancer Chemotherapy: A Real-World Bicentric Experience;Cureus;2024-03-21

2. Adverse effect signature extraction and prediction for drugs treating COVID-19;Frontiers in Genetics;2022-11-04

3. Anti-angiogéniques : mécanisme d’action et néphrotoxicité;Néphrologie & Thérapeutique;2022-02

4. Toxicité rénale des anticancéreux;Néphrologie & Thérapeutique;2021-12

5. Onconephrology;Approaches to Chronic Kidney Disease;2021-10-19